Response to Comments: Transurethral Waterjet Ablation of the Prostate

This document is a response-to-comments notice regarding the Local Coverage Determination L38549 for Transurethral Waterjet Ablation of the Prostate. It records the comment period (9/1/22–10/15/22) and the LCD effective date (1/29/23) but does not itself state coverage indications, limitations, or documentation requirements; consult LCD L38549 for the substantive coverage policy.

"This document is a response-to-comments notice for LCD L38549 (Transurethral Waterjet Ablation of the Prostate); refer to LCD L38549 for the official coverage criteria and clinical indications."

Sign up to see full coverage criteria, indications, and limitations.